Viewing Study NCT02312102


Ignite Creation Date: 2025-12-25 @ 3:54 AM
Ignite Modification Date: 2026-03-04 @ 12:45 PM
Study NCT ID: NCT02312102
Status: COMPLETED
Last Update Posted: 2025-06-17
First Post: 2014-12-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module